Next Issue
Volume 13, 09
Previous Issue
Volume 13, 06
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
0.4
Journals
Cardiovascular Medicine
Volume 13
Issue 7
cardiovascmed-logo

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 13, Issue 7 (08 2010) – 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
1 pages, 134 KB  
Communication
Annual Report 2009 from the “Working Group for Echocardiography and Cardiac Imaging”
by Manfred Ritter, Jean Bérubé, Cédric Vuille, Michael Zellweger, Xavier Jeanrenaud and Christian Seiler
Cardiovasc. Med. 2010, 13(7), 249; https://doi.org/10.4414/cvm.2010.01514 - 11 Aug 2010
Viewed by 16
Abstract
In the January 2009 number of Kardiovaskuläre Medizin the Swiss Society of Cardiology published “Recommendations for quality maintenance in echocardiography”, [...] Full article
2 pages, 185 KB  
Interesting Images
Aneurysm of the Left Circumflex Coronary Artery
by Christian Arranto, Christoph Auf der Maur and Paul Erne
Cardiovasc. Med. 2010, 13(7), 247; https://doi.org/10.4414/cvm.2010.01511 - 11 Aug 2010
Viewed by 12
Abstract
A 54-year-old man was hospitalised because of an inferior ST-elevation myocardial infarction [..] Full article
2 pages, 169 KB  
Interesting Images
Cardiac Arrest in a 22-Year-Old College Student
by Marcus Mutschelknauss, Mona Hellstern, Dagmar I. Keller and Christian Sticherling
Cardiovasc. Med. 2010, 13(7), 245; https://doi.org/10.4414/cvm.2010.01513 - 11 Aug 2010
Viewed by 12
Abstract
We present the case of a young woman who was resuscitated on an aircraft shortly before take-off [...] Full article
2 pages, 845 KB  
Interesting Images
Skitour
by Corinna Brunckhorst
Cardiovasc. Med. 2010, 13(7), 243; https://doi.org/10.4414/cvm.2010.01520 - 11 Aug 2010
Viewed by 13
Abstract
Ein 36-jähriger Patient stellte sich bei seinem Hausarzt vor, nachdem er auf einer Skitour eine Woche zuvor Dyspnoe, Herzrasen, ein thorakales Druckgefühl und Schwindel verspürt hatte [...] Full article
3 pages, 243 KB  
Case Report
Hyperthyreose und Pulmonale Hypertonie
by Dürst Urs Niklaus, Binz Katharina, Brunschwig Thierry and Engel Hermann
Cardiovasc. Med. 2010, 13(7), 240; https://doi.org/10.4414/cvm.2010.01512 - 11 Aug 2010
Viewed by 9
Abstract
Pulmonary hypertension in adults with hyperthyroidism is often unrecognised. Although the mechanism is uncertain, the reversal of pulmonary hypertension following restoration to an euthyroid state supports a causal relationship. This case report is of a 71-year-old woman who presented with Morbus Basedow. Echocardiography [...] Read more.
Pulmonary hypertension in adults with hyperthyroidism is often unrecognised. Although the mechanism is uncertain, the reversal of pulmonary hypertension following restoration to an euthyroid state supports a causal relationship. This case report is of a 71-year-old woman who presented with Morbus Basedow. Echocardiography showed moderate pulmonary hypertension with normalisation under the specific therapy. Full article
5 pages, 205 KB  
Article
Current Outpatient Therapy of Stable Coronary Artery Disease in Switzerland
by Stéphane Cook, Jean-Christophe Stauffer, Otto M. Hess and Paul Erne
Cardiovasc. Med. 2010, 13(7), 235; https://doi.org/10.4414/cvm.2010.01516 - 11 Aug 2010
Cited by 1 | Viewed by 18
Abstract
Principle: Stable coronary artery disease (CAD) is frequent in Switzerland. Heart rate plays a key role in the ischaemic cascade and its control remains a milestone in treatment of patients with symptomatic angina pectoris. The aim of the present study was to take [...] Read more.
Principle: Stable coronary artery disease (CAD) is frequent in Switzerland. Heart rate plays a key role in the ischaemic cascade and its control remains a milestone in treatment of patients with symptomatic angina pectoris. The aim of the present study was to take a snapshot of the current cardiovascular risk profile and drug therapy of patients suffering from stable CAD in outpatient clinics in Switzerland, with special emphasis on resting heart rate (RHR) and its association with therapy, symptoms and quality of life. Methods: Prospective cross-sectional survey at 28 cardiologist care practices in Switzerland. Diagnoses, cardiovascular risk factors, CAD history and baseline clinical examination were systematically registered. General wellbeing and incidence of angina pectoris on daily activities were estimated using a modified Seattle quality of life (QoL) questionnaire. Results: Between February 2007 and July 2008, 283 patients (202 men and 81 women) with stable CAD were included. 126 patients (44%) presented an RHR of 70 bpm or more and composed the high RHR group, whereas 156 patients (56%) had an RHR <70 bpm. Frequency and severity of angina pectoris rise proportionally to RHR. Moreover, patients in the higher RHR group restrict their daily activities due to fear of angina pectoris occurrence. Conclusions: Patients with stable CAD suffer from angina pectoris despite revascularisation procedures and intensive medical therapy. RHR correlates with the frequency and severity of angina pectoris and restricts both QoL and physical activity. Full article
7 pages, 532 KB  
Proceeding Paper
Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
by Amir-Ali Fassa and Ulrich Sigwart
Cardiovasc. Med. 2010, 13(7), 228; https://doi.org/10.4414/cvm.2010.01519 - 11 Aug 2010
Cited by 2 | Viewed by 13
Abstract
Hypertrophic obstructive cardiomyopathy can cause symptoms such as dyspnoea, angina pectoris and syncope. First-line pharmacological therapy includes betablockers, verapamil and disopyramid. However, 5–10% of patients with left ventricular outflow tract gradient are unresponsive to medical treatment. Therapeutic options for patients with drug-resistant symptoms [...] Read more.
Hypertrophic obstructive cardiomyopathy can cause symptoms such as dyspnoea, angina pectoris and syncope. First-line pharmacological therapy includes betablockers, verapamil and disopyramid. However, 5–10% of patients with left ventricular outflow tract gradient are unresponsive to medical treatment. Therapeutic options for patients with drug-resistant symptoms include surgical myectomy (SM) and alcohol septal ablation (ASA). The former has been performed for more than 50 years and involves surgical resection of the basal septum. The latter, which was proposed as an alternative to surgical therapy 15 years ago, is a catheter-based technique involving selective injection of ethanol in a septal coronary artery to induce a scar at the level of the basal septum. Both procedures are associated with excellent symptom relief and long-term survival. Complication rates are also comparable, although complete heart block requiring permanent pacemaker implantation tends to occur more frequently following ASA. Moreover, SM and ASA have never been compared by a randomised controlled trial. The choice of treatment should therfore be based on local availability and expertise as well as patient’s preference and associated conditions, taking into account the benefits and limitations of both techniques. Full article
7 pages, 311 KB  
Review
Traitement Invasif de L’insuffisance Artérielle des Membres Inférieurs
by Robert F. Bonvini, Nicolas Murith, Afksendiyos Kalangos and Marco Roffi
Cardiovasc. Med. 2010, 13(7), 221; https://doi.org/10.4414/cvm.2010.01515 - 11 Aug 2010
Viewed by 15
Abstract
Endovascular and surgical treatment of peripheral arterial disease. Lower extremity peripheral arterial disease (PAD) is a manifestation of atherosclerosis, with a prevalence ranging from 4% to 12% in the adult population and increasing up to 20% in patients older than 70 years of [...] Read more.
Endovascular and surgical treatment of peripheral arterial disease. Lower extremity peripheral arterial disease (PAD) is a manifestation of atherosclerosis, with a prevalence ranging from 4% to 12% in the adult population and increasing up to 20% in patients older than 70 years of age. PAD is a marker of systemic atherosclerosis and is associated with an increased cardiovascular morbidity and mortality. Therapeutic strategies are firstly aimed at reducing systemic cardiovascular risk burden. Therefore, intensive factor risk modification, and antiplatelet therapy should be implemented in all patients with PAD. Endovascular and surgical treatment are highly valuable to improve claudication, rest pain and ulcer healing and the recent advances in the field will be discussed in this review. Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-8
Previous Issue
Next Issue
Back to TopTop